Aurobindo Pharma – News Portal

Aurobindo Pharma arm acquires non-oncology portfolio of Khandelwal Labs

January 1, 2026January 1, 2026cpooldigitalLeave a Comment

[ad_1] Aurobindo Pharma. File | Photo Credit: Special Arrangement Aurobindo Pharma subsidiary Auro Pharma is acquiring the non-oncology prescription formulations business of Khandelwal Laboratories on a going concern basis, on slump sale basis. It is for a cash consideration of ₹325 crore subject to true-up adjustments for the working capital as provided for in the […]

U.S. FDA issues five observations to Aurobindo Pharma arm

December 19, 2025December 19, 2025cpooldigitalLeave a Comment

[ad_1] The U.S. FDA inspected Unit-IV of APL Healthcare in SPSR Nellore District, Andhra Pradesh, from December 8 to 17 and issued a Form 483 with five observations. | Photo Credit: Reuters The U.S.Food and Drug Administration has issued five observations to Aurobindo Pharma subsidiary APL Healthcare’s unit in Andhra Pradesh. The U.S.FDA inspected Unit-IV […]

Aurobindo Pharma arm gets U.S. FDA nod for cancer drug copy

March 8, 2023March 8, 2023cpooldigitalLeave a Comment

[ad_1] Aurobindo Pharma’s subsidiary Eugia Pharma Specialities will manufacture and market cancer drug Lenalidomide Capsules. | Photo Credit: The Hindu Drugmaker Aurobindo Pharma’s subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market cancer drug Lenalidomide Capsules, in different strengths. The approved product is […]

Aurobindo Pharma net slides 41% on lower revenue, intense competition

November 12, 2022November 12, 2022cpooldigitalLeave a Comment

[ad_1] Total revenue from operations at ₹5,739.3 crore (₹5,941.9 crore) was 3.4% lower during the quarter Total revenue from operations at ₹5,739.3 crore (₹5,941.9 crore) was 3.4% lower during the quarter Drugmaker Aurobindo Pharma’s consolidated net profit declined more than 41% for the September quarter to ₹410.3 crore on the back of lower revenue from […]

Andhra Pradesh: Aurobindo Pharma conducts skill training for youth in Srikakulam

August 25, 2022August 25, 2022cpooldigitalLeave a Comment

[ad_1] Aurobindo Pharma Limited senior vice-president (corporate-HR) U.N.B. Raju on Thursday said that the company was according a top priority to providing jobs to the local residents after providing them skill-oriented training. He presented certificates to 25 youth who have successfully completed a four-month training programme jointly organised by Dr. B.R. Ambedkar University and the […]

Aurobindo Pharma Q1 net slides 32% to ₹520 cr.

August 11, 2022August 11, 2022cpooldigitalLeave a Comment

[ad_1] Drugmaker Aurobindo Pharma reported first-quarter consolidated net profit slid more than 32% to ₹520.3 crore. The net profit declined on an almost 9% increase in net sales to ₹6,176.8 crore (₹5,691.8 crore). Total income at ₹6,276.5 crore (₹5,811.8 crore) was almost 8% higher. The EBITDA margin stood at 15.5% as against 21.2% in the […]

SEBI warns Aurobindo Pharma over U.S. FDA audit disclosure

June 27, 2022June 28, 2022cpooldigitalLeave a Comment

[ad_1] Firm disclosed “very limited and restricted information” to stock exchanges about an U.S. FDA plant audit Firm disclosed “very limited and restricted information” to stock exchanges about an U.S. FDA plant audit The Securities and Exchange Board of India (SEBI) has issued a warning letter to Aurobindo Pharma for disclosing “very limited and restricted […]